UBIO
Proshares UltraPro NASDAQ Biotechnology
UBIO
UBIO
Delisted
UBIO was delisted on the 27th of March, 2020.
7 hedge funds and large institutions have $3.4M invested in Proshares UltraPro NASDAQ Biotechnology in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
7
Holding in Top 10
–
Calls
$552K
Puts
$235K
Top Buyers
| 1 | +$1.28M | |
| 2 | +$818K | |
| 3 | +$188K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$101K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
+$9.75K |